Luis Calderón – General Manager, Alexion Mexico
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body’s immune response and can destroy healthy tissue in certain patients. Alexion discovered and developed Soliris® (eculizumab), a first-in-class terminal complement inhibitor, approved in the United States, Canada, European Union, Australia, and Japan as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH). Alexion is working urgently to investigate Soliris and additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.
Contact details
Alexion
Paseo de los Tamarindos 90
Torre 1 Piso 6 Oficina A
Col. Bosque de la Lomas, Del. Cuajimalpa,
C.P. 05120, México DF
MEXICO
Tel: +52 (55) 5047 1500
Website: http://alxn.com/
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Pablo Escandón shares his experience as CEO of Nadro and how retail changes have transformed the Mexican market, his perspectives on the accessibility of medicine for Mexicans and the challenges…
Celgene is committed to improving the lives of patients through innovation. The country manager of the recently opened Mexico affiliate explains the importance of having a direct presence in the…
Philips aims at becoming the leading provider of solutions across the full ‘continuum of care’. The general manager of the healthcare division in Mexico explains how the company has made…
seca is turning ten years old in Mexico in 2015. The general director of the Mexico affiliate discusses how the company foresaw the growing demand for medical measuring systems and…
‘Poverty is fought with health, education and, above all, employment and more employment’. This is the vision Carlos Slim has for Mexico. The CEO of the Carlos Slim Foundation discusses…
The general manager for Mexico, Central America and Caribbean shares his point of view about the announced healthcare reform, the opportunities and challenges it presents and how BD is adapting…
Worldwide, Bayer is experiencing a strong business momentum thanks to an avalanche of innovation. The general manager of Bayer HealthCare Pharmaceuticals in Mexico shares his perspectives about the recent developments…
After Brazil, Torrent is looking to strengthen its foothold in the Mexican market. The general manager of the local affiliate explains the opportunities Latin America offers to Indian companies, how…
The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life science practice of the…
In order to mark its 65th anniversary, the Mexican Association of Pharmaceutical Research Industries (AMIIF) organized on March 25-26, 2015 in Mexico City the Semana de la Innovación, a week…
Vaccination is one of the most important achievements of mankind. The general manager of Sanofi Pasteur Mexico shares the company’s vision behind the decision to choose Mexico as one of…
The Japan-based company is changing into a new Takeda. José Manuel Caamaño, general manager of Takeda Mexico, talks about the transformation process the company is going through to become a…
See our Cookie Privacy Policy Here